OncLive | Bringing the Global Oncology Community Together

Education ▼

PER is hosting the 2nd Annual International Congress on Oncology Pathology^™ | June 23rd in NYC Hematologic Malignancies Medical Crossfire in NYC on July 14th! Register today!

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Gastrointestinal Cancer

Latest News

Agarwal Addresses Sequencing Challenges in Kidney Cancer

Neeraj Agarwal, MD, discusses his preferred sequencing strategies for treating patients with kidney cancer, and ongoing immunotherapy research in the field. Read More >>

Singh Discusses Developments in Uterine Sarcoma

FDA Strategizes to Step Up Introduction of Lower-Cost Drugs and NGS

Blinatumomab Granted Full EU Approval for B-cell Precursor ALL

Polatuzumab Vedotin Plus R-CHOP Being Explored in DLBCL Trial

Study Explores ADT Alternative in Localized Prostate Cancer Recurrence

View More Stories >>

View Conference Coverage

2018 World Congress on GI Cancer

2018 European Hematology Association Congress

2018 State of the Science Summit on Genitourinary Cancers

2018 ASCO Annual Meeting

2018 ASPHO Conference

Dr. Rini Discusses Atezolizumab Plus Bevacizumab in RCC

$Dr. Davids Discusses Duvelisib in Relapsed/Refractory CLL$

Dr. Davids Discusses Duvelisib in Relapsed/Refractory CLL

Dr. Mitri on Neratinib and Pertuzumab in HER2-Amplified Breast Cancer

Dr. Grivas on Immunotherapy in Advanced Urothelial Cancer

Dr. Wirth on the Use of Lenvatinib in Hypertensive Patients With Thyroid Cancer

Dr. Singh on the Use of Chemotherapy in Patients With Uterine Leiomyosarcomas

Dr. Bekaii-Saab on Immunotherapy in Colorectal Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Managing Advanced Prostate Cancer in the Future

Hereditary Prostate Cancer Testing in Practice

Improvements in Detecting and Treating Metastatic CRPC

Renal Cell Carcinoma: An Evolving Treatment Landscape

OncLive houses thousands of videos that provide updates and information.
See more Videos

HCC: Emerging Therapies

Use of Immunotherapy for HCC

The Evolving Treatment Landscape of CLL

$Relapsed/Refractory CLL: Evaluating Other Novel Agents$

$Treatment of Relapsed/Refractory mHCC$

$Novel Approaches to Treating Relapsed/Refractory CLL$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

The Evolving Landscape of Immunotherapy for NSCLC

A video editorial series that features expert opinions on multiple areas of focus.

View more >>>

Featured

MRD-Positive ALL: Personal Approaches to Treatment

A unique opportunity to view lively discussions featuring peer-to-peer exchanges that provide authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in Cervical Cancer, Ovarian Cancer, and CLL, and More